Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Oncology Metrics and Cureline have reached an agreement to collaborate on oncology biospecimen procurement and management with a goal to facilitate the collection and preservation of high-quality pre-treatment and post-treatment samples with maximum efficiency.
Subscribe to our email newsletter
The collaboration between Oncology Metrics’s sample procurement network Cure Pace and Cureline is expected to improve the access of industrial and academic researchers to high-quality biospecimens.
Olga Potapova, founder and CEO of Cureline, said that she views the collaboration as a unique opportunity to provide to academia and the industry cancer biospecimens collected from diverse ethnic background populations through Cureline’s clinical network in eastern Europe and Asia and through the Oncology Metrics’s clinical network in the US.
Commenting on the collaboration, Warren Dodge, president and CEO of Oncology Metrics, said: “By leveraging the scientific expertise and access to tissue and our domestic access to serum and fresh whole blood, we become a much better resource for the scientists looking to advance the treatment of cancer.”